Zobrazeno 1 - 10
of 258
pro vyhledávání: '"Halbert G"'
Publikováno v:
In International Journal of Pharmaceutics 5 September 2024 662
Publikováno v:
In International Journal of Pharmaceutics 25 March 2023 635
Autor:
Eschweiler, S., Ramirez-Suastegui, C., Li, Y., King, E., Chudley, L., Thomas, J., Wood, O., von Witzleben, A., Jeffrey, D., McCann, K., Simon, H., Mondal, M., Wang, A., Dicker, M., Lopez-Guadamillas, E., Chou, T.-F., Dobbs, N.A., Essame, L., Acton, G., Kelly, F., Halbert, G., Sacco, J.J., Schache, A.G., Shaw, R., McCaul, J.A., Paterson, C., Davies, J.H., Brennan, Peter A., Singh, R.P., Loadman, Paul, Wilson, W., Hackshaw, A., Seumois, G., Okkenhaug, K., Thomas, G.J., Jones, T.M., Ay, F., Friberg, G., Kronenberg, M., Vanhaesebroeck, B., Vijayananad, P., Ottensmeier, C.H.
Yes
Phosphoinositide 3-kinase δ (PI3Kδ) has a key role in lymphocytes, and inhibitors that target this PI3K have been approved for treatment of B cell malignancies1–3. Although studies in mouse models of solid tumours have demonstrated that
Phosphoinositide 3-kinase δ (PI3Kδ) has a key role in lymphocytes, and inhibitors that target this PI3K have been approved for treatment of B cell malignancies1–3. Although studies in mouse models of solid tumours have demonstrated that
Externí odkaz:
http://hdl.handle.net/10454/18980
Autor:
Danson, S.J. *, Johnson, P., Ward, T.H., Dawson, M., Denneny, O., Dickinson, G., Aarons, L., Watson, A., Jowle, D., Cummings, J., Robson, L., Halbert, G., Dive, C., Ranson, M.
Publikováno v:
In Annals of Oncology July 2011 22(7):1653-1660
Autor:
Cruickshank, G.S., Ngoga, D., Detta, A., Green, S., James, N.D., Wojnecki, C., Doran, J., Hardie, J., Chester, M., Graham, N., Ghani, Z., Halbert, G., Elliot, M., Ford, S., Braithwaite, R., Sheehan, T.M.T., Vickerman, J., Lockyer, N., Steinfeldt, H., Croswell, G., Chopra, A., Sugar, R., Boddy, A.
Publikováno v:
In Applied Radiation and Isotopes 2009 67(7) Supplement:S31-S33
Autor:
de Bono, J.S., Lord, S., Yap, C., Miranda, S., Veal, G.J., Chandran, K., Paschalis, A., Peron, C., Rekowski, J., Gurel, B., Paisley, D., McGuigan, L., Ingram, P.J., Kwek, K.Y., Halbert, G., Westwood, N.B., Griffin, A.E., Kostaras, L., Boyd-Kirkup, J.D., Walter, H.S.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S479-S480
Autor:
Nielsen, K., Smith, P., Yu, W.L., Elmgren, C., Halbert, G., Nicoletti, P., Perez, B., Conde, S., Samartino, L., Nicola, A., Bermudez, R., Renteria, T.
Publikováno v:
In Veterinary Immunology and Immunopathology 2008 125(3):246-250
Autor:
Steward, W.P., Middleton, M., Benghiat, A., Loadman, Paul, Hayward, C., Walter, S., Ford, S., Halbert, G., Patterson, Laurence H., Talbot, D.
Background: AQ4N (1,4-bis[[2-(dimethylamino)ethyl] amino]-5,8-dihydroxyanthracene-9, 10-dione bis-N-oxide dihydrochloride) is a prodrug which is selectively activated within hypoxic tissues to AQ4, a topoisomerase II inhibitor and DNA intercalator. P
Externí odkaz:
http://hdl.handle.net/10454/3982
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
CMAC UK Showcase
University of Strathclyde
University of Strathclyde
Linking a hot-melt-extrusion (HME) process to 3D printing offers the ability for rapid prototyping of dose forms, whilst also allowing for personalisation of the dosage form to the patient's needs. However, process development can be lengthy and labo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::27ad5c851108329ab52888c6d1173df6
https://strathprints.strath.ac.uk/71549/1/Prasad_etal_CMAC2019_Enabling_future_manufacture_of_dose_forms_screening_tools_for_an_HME_3D.pdf
https://strathprints.strath.ac.uk/71549/1/Prasad_etal_CMAC2019_Enabling_future_manufacture_of_dose_forms_screening_tools_for_an_HME_3D.pdf